Seeking Alpha

Seeking Alpha Portfolio App for iPad

This Market Current was sent to 1,048 people who get email alerts on HALO.

Get email alerts on HALO »

Market Currents

Halozyme Therapeutics (HALO) is halted with news pending.

Friday, December 21, 2012, 7:33 AM ET
Halozyme Therapeutics (HALO) is halted with news pending.

This Market Current was sent to 1,048 people who get email alerts on HALO.

Get email alerts on HALO »

Share this Market Current

Short URL:

Other date

DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles

American Medical Association Decision Can Boost Arena, Vivus, And Orexigen
12:22 AM • Spencer Osborne
Sarepta And Eteplirsen: Will 12 Patients Be Enough For The FDA?
6:44 PM • Cory Renauer
Zoetis Exchange Offer Update
5:23 PM • Pine Research & Trading
Venaxis, Inc: A Long-Term Investment With Potential For Substantial Gains
2:14 PM • Alexander Maxwell
AtriCure Mid-Trial Results Highly Encouraging
12:59 PM • Spencer Ross
Why Endocyte's Small Molecule Drug Conjugates + Imaging Platform Is Undervalued
12:25 PM • Bay Area Biotech Investor
Why I'm Betting Big On MusclePharm
9:44 AM • Buffett Junior
Short Sellers Flee Questcor On Sentiment Reversal
9:23 AM • Brian L. Wilson
Big Opportunities For Implant Sciences: An Interview With The CEO
9:06 AM • Daniel Lauchheimer
Revisiting Oculus: Earnings Do Little To Ease The Pain
8:25 AM • Wall Street Advisors
Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes Market
8:01 AM • StockMatusow
Where Is Biotechnology's Next 'Anti-PD-1'?
7:57 AM • Brian Nichols
Humana: Misunderstood And 35% Undervalued
7:00 AM • Mike Williams
Focus On Medtronic
2:53 AM • Robert Freedland
Isis Pharmaceuticals Making Antisense
5:25 PM • Cory Renauer

More Latest Articles »